(Q50503138)

English

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.

scientific article published in February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

atrial fibrillation

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John W. Eikelboom

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Martin O'Donnell

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Graeme J. Hankey

9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Olga Shestakovska

object named as

Olga Shestakovska

10

0 references

6

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

Hans-Christoph Diener

1

object named as

Hans-Christoph Diener

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

11

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Stefan H Hohnloser

8

object named as

Stefan H Hohnloser

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Campbell D Joyner

4

object named as

Campbell D Joyner

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

AVERROES Steering Committee and Investigators

12

object named as

AVERROES Steering Committee and Investigators

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

author name string

Stuart J Connolly

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Robert G Hart

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

11

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

225-231

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin discontinuation after starting warfarin for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Calculating the number needed to treat for trials where the outcome is time to an event

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Why do patients with atrial fibrillation not receive warfarin?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970017-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(12)70017-0

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22305462

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50503138&oldid=1754951154"